[Comparison of two national quality of life surveys for patients with end stage renal disease between 2005-2007 and 2011: indicators slightly decreased]. Beauger, Davy; Gentile, Stéphanie; Jacquelinet, Christian; Dussol, Bertrand; Briançon, Serge. Néphrologie & Thérapeutique. 2015; 88-96: p.88-96. doi:10.1016/j.nephro.2014.10.003Article
How individual participant data meta-analyses have influenced trial design, conduct, and analysis. Tierney, J. F.; Pignon, J. P.; Gueffyier, F.; Clarke, M.; Askie, L.; Vale, C. L.; Burdett, S.; Cochrane, I. P. D. Meta-analysis Methods Group. J Clin Epidemiol. 2015; 1325-35: p.1325-35. doi:10.1016/j.jclinepi.2015.05.024 10.1016/j.jclinepi.2015.05.024. Epub 2015 Jun 3.Article
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). Gourgou-Bourgade, S.; Cameron, D.; Poortmans, P.; Asselain, B.; Azria, D.; Cardoso, F.; A'Hern, R.; Bliss, J.; Bogaerts, J.; Bonnefoi, H.; Brain, E.; Cardoso, M. J.; Chibaudel, B.; Coleman, R.; Cufer, T.; Dal Lago, L.; Dalenc, F.; De Azambuja, E.; Debled, M.; Delaloge, S.; Filleron, T.; Gligorov, J.; Gutowski, M.; Jacot, W.; Kirkove, C.; MacGrogan, G.; Michiels, S.; Negreiros, I.; Offersen, B. V.; Penault Llorca, F.; Pruneri, G.; Roche, H.; Russell, N. S.; Schmitt, F.; Servent, V.; Thürlimann, B.; Untch, M.; van der Hage, J. A.; van Tienhoven, G.; Wildiers, H.; Yarnold, J.; Bonnetain, F.; Mathoulin-Pélissier, S.; Bellera, C.; Dabakuyo-Yonli, T. S.. Ann. Oncol.. 2015; 2505-6: p.2505-6Article
Dose finding with longitudinal data: simpler models, richer outcomes. Paoletti, X.; Doussau, A.; Ezzalfani, M.; Rizzo, E.; Thiebaut, R.. Stat Med. 2015; 2983-98: p.2983-98. doi:10.1002/sim.6552 10.1002/sim.6552. Epub 2015 Jun 24.Article
Predictors of HbA1c over 4 years in people with type 2 diabetes starting insulin therapies: The CREDIT study. Balkau, Beverley; Calvi-Gries, Françoise; Freemantle, Nick; Vincent, Maya; Pilorget, Valerie; Home, Philip D.. Diabetes Research and Clinical Practice. 2015; 108: p.432-440. doi:10.1016/j.diabres.2015.02.034Article
Impact of a printed decision aid on patients' intention to undergo prostate cancer screening: a multicentre, pragmatic randomised controlled trial in primary care. Tran, V. T.; Kisseleva-Romanova, E.; Rigal, L.; Falcoff, H.. Br J Gen Pract. 2015; e295-304: p.e295-304. doi:65/634/e295 [pii] 10.3399/bjgp15X684817Article
Changes of Cardiac Function During Ultradistance Trail Running. Jouffroy, Romain; Caille, Vincent; Perrot, Stéphane; Vieillard-Baron, Antoine; Dubourg, Olivier; Mansencal, Nicolas. The American Journal of Cardiology. 2015; : . doi:10.1016/j.amjcard.2015.07.045Article
Annual cost of stable coronary artery disease in France: A modeling study. Caruba, Thibaut; Chevreul, Karine; Zarca, Kevin; Cadier, Benjamin; Juillière, Yves; Dubourg, Olivier; Sabatier, Brigitte; Danchin, Nicolas. Archives of Cardiovascular Diseases. 2015; 108: p.576-588. doi:10.1016/j.acvd.2015.06.006Article
[Monitoring network for vulnerable children in the Pays de la Loire ("Grandir ensemble" - Cohort LIFT): 10 years of activity 2003-2013]. Branger, B.; Rouger, V.; Berlie, I.; Beucher, A.; Flamant, C.; N'guyen The Tich, S.; Garcia, J.; Brossier, J.-P.; Montcho, Y.; Hanf, M.; Roze, J.-C.; 160 médecins référents du réseau. Archives De Pediatrie: Organe Officiel De La Societe Francaise De Pediatrie. 2015; 22: p.171-180. doi:10.1016/j.arcped.2014.10.027Article
Common variants at the 9q22.33, 14q13.3 and ATM loci, and risk of differentiated thyroid cancer in the Cuban population. Pereda, Celia M.; Lesueur, Fabienne; Pertesi, Maroulio; Robinot, Nivonirina; Lence-Anta, Juan J.; Turcios, Silvia; Velasco, Milagros; Chappe, Mae; Infante, Idalmis; Bustillo, Marlene; García, Anabel; Clero, Enora; Xhaard, Constance; Ren, Yan; Maillard, Stéphane; Damiola, Francesca; Rubino, Carole; Salazar, Sirced; Rodriguez, Regla; Ortiz, Rosa M.; de Vathaire, Florent. BMC genetics. 2015; 22: p.22. doi:10.1186/s12863-015-0180-5Article